ARRIVENT BIOPHARMA, INC. (AVBP) Net income 2023–2025
ARRIVENT BIOPHARMA, INC. (AVBP) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$166.3MFY2025 · since FY2023: -$69.3M → -$166.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$166.3M | -106.6% |
| FY2024 | -$80.5M | -16.1% |
| FY2023 | -$69.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice